BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15501785)

  • 1. Modeling the development of acquired clinical immunity to Plasmodium falciparum malaria.
    Gatton ML; Cheng Q
    Infect Immun; 2004 Nov; 72(11):6538-45. PubMed ID: 15501785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression.
    Bachmann A; Bruske E; Krumkamp R; Turner L; Wichers JS; Petter M; Held J; Duffy MF; Sim BKL; Hoffman SL; Kremsner PG; Lell B; Lavstsen T; Frank M; Mordmüller B; Tannich E
    PLoS Pathog; 2019 Jul; 15(7):e1007906. PubMed ID: 31295334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential, ordered acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 domains.
    Cham GK; Turner L; Lusingu J; Vestergaard L; Mmbando BP; Kurtis JD; Jensen AT; Salanti A; Lavstsen T; Theander TG
    J Immunol; 2009 Sep; 183(5):3356-63. PubMed ID: 19675168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG antibodies to endothelial protein C receptor-binding cysteine-rich interdomain region domains of Plasmodium falciparum erythrocyte membrane protein 1 are acquired early in life in individuals exposed to malaria.
    Turner L; Lavstsen T; Mmbando BP; Wang CW; Magistrado PA; Vestergaard LS; Ishengoma DS; Minja DT; Lusingu JP; Theander TG
    Infect Immun; 2015 Aug; 83(8):3096-103. PubMed ID: 26015475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D7-Derived Plasmodium falciparum erythrocyte membrane protein 1 is a frequent target of naturally acquired antibodies recognizing protein domains in a particular pattern independent of malaria transmission intensity.
    Joergensen L; Vestergaard LS; Turner L; Magistrado P; Lusingu JP; Lemnge M; Theander TG; Jensen AT
    J Immunol; 2007 Jan; 178(1):428-35. PubMed ID: 17182581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PfEMP1 - A Parasite Protein Family of Key Importance in Plasmodium falciparum Malaria Immunity and Pathogenesis.
    Hviid L; Jensen AT
    Adv Parasitol; 2015 Apr; 88():51-84. PubMed ID: 25911365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria.
    Warimwe GM; Abdi AI; Muthui M; Fegan G; Musyoki JN; Marsh K; Bull PC
    Infect Immun; 2016 May; 84(5):1331-1335. PubMed ID: 26883585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum var gene expression homogeneity as a marker of the host-parasite relationship under different levels of naturally acquired immunity to malaria.
    Warimwe GM; Recker M; Kiragu EW; Buckee CO; Wambua J; Musyoki JN; Marsh K; Bull PC
    PLoS One; 2013; 8(7):e70467. PubMed ID: 23922996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians.
    Scopel KK; da Silva-Nunes M; Malafronte RS; Braga EM; Ferreira MU
    Am J Trop Med Hyg; 2007 Jun; 76(6):1084-91. PubMed ID: 17556615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the Plasmodium falciparum Proteins MSPDBL1 and MSPDBL2 Opsonize Merozoites, Inhibit Parasite Growth, and Predict Protection From Clinical Malaria.
    Chiu CY; Hodder AN; Lin CS; Hill DL; Li Wai Suen CS; Schofield L; Siba PM; Mueller I; Cowman AF; Hansen DS
    J Infect Dis; 2015 Aug; 212(3):406-15. PubMed ID: 25646353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of phenotypic diversity within a set of virulence encoding genes of the malaria parasite Plasmodium falciparum.
    Holding T; Recker M
    J R Soc Interface; 2015 Dec; 12(113):20150848. PubMed ID: 26674193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria.
    Magistrado PA; Lusingu J; Vestergaard LS; Lemnge M; Lavstsen T; Turner L; Hviid L; Jensen AT; Theander TG
    Infect Immun; 2007 May; 75(5):2415-20. PubMed ID: 17283085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection.
    Scholzen A; Sauerwein RW
    Trends Parasitol; 2013 May; 29(5):252-62. PubMed ID: 23562778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between responses to the rhoptry-associated membrane antigen of Plasmodium falciparum and immunity to malaria infection.
    Topolska AE; Richie TL; Nhan DH; Coppel RL
    Infect Immun; 2004 Jun; 72(6):3325-30. PubMed ID: 15155636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum.
    Pasternak ND; Dzikowski R
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1463-6. PubMed ID: 19150410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian Amazon.
    Torres KJ; Castrillon CE; Moss EL; Saito M; Tenorio R; Molina DM; Davies H; Neafsey DE; Felgner P; Vinetz JM; Gamboa D
    J Infect Dis; 2015 Apr; 211(8):1342-51. PubMed ID: 25381370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.
    Makobongo MO; Keegan B; Long CA; Miller LH
    J Infect Dis; 2006 Mar; 193(5):731-40. PubMed ID: 16453270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccine.
    Bull PC; Abdi AI
    Parasitology; 2016 Feb; 143(2):171-86. PubMed ID: 26741401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.